FindTrial
Sign In

Conceptual study on Covid 19 as per Ayurveda and role Of Ayush 64 in its managment.

Conceptual study of Janapadodhavansaand a retrospective survey study to understand the role of Ayush 64 in Covid 19 patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/05/042520
Enrollment
280
Registered
2022-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J989- Respiratory disorder, unspecified

Interventions

None listed

Sponsors

All India Istitute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who have recovered from Covid 19 with RT-PCR negative. 2.Patients who are suffered from Covid 19 complications with test report RT-PCR negative. 3.Patients who have taken AYUSH 64 minimum 7 days with or without any other Ayurvedic medicine for the management of Covid 19. 4.Patients Age group 18 to 60 years.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from any psychosomatic conditions.] 2. The patients who have volunteered to discontinue the study.

Design outcomes

Primary

MeasureTime frame
Primary outcome: â?¢ To explore the result of AYUSH 64 in Covid 19 patient. Secondary Objective: â?¢ To scrutinize the role of AYUSH 64 effectiveness as per severity of covid19 patient. â?¢ To understand the applied aspect of Janapadodhvansa.Timepoint: 4 week—

Secondary

MeasureTime frame
â?¢ To scrutinize the role of AYUSH 64 effectiveness as per severity of covid19 patient. â?¢ To understand the applied aspect of à¤?नपदà¥?द ?धवà¤?स.Timepoint: 4 week—

Countries

India

Contacts

Public ContactProf Mahesh Vyas

ALL INDIA INSTITUTE OF AYURVEDA NEW DELHI

kamalkumar324@gmail.com9785031320

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026